Harvard, Tufts med students stage protest at ‘biased’ $2.9B drug development figure

Ben Adams Around two dozen students from Harvard Medical School and Tufts University as well as members of health activist groups protested in front of the Tufts Center for the Study ...

Delay In Major Health Law Provision Raises Doubts At Critical Stage Of Rollout

barbara.lempert By Jay Hancock and Julie Appleby KHN Staff Writers The Obama administration’s decision Tuesday to delay a major component of the Affordable Care Act ...

ADA roundup: Eli Lilly, Sanofi, Novo vie for center stage at diabetes confab

Ryan McBride We're put together snippets from the top ADA stories over the weekends with links to the full articles below. If you haven't done so already, please open the special ...

Kineta and Rosa form strategic alliance for next stage of clinical development of lead drug candidate Shk-186

barbara.lempert SEATTLE, WA, June 14, 2013 – Kineta, Inc. a biotechnology company focused on the development of novel modulating drugs for critical disease areas, announced today ...

Bristol-Myers’ immunotherapy drug nivolumab takes center stage at ASCO

John Carroll FierceBiotech News

Biotech upstart joins Big Pharma cast on high-profile “breakthrough” stage

John Carroll   Up until now the FDA has reserved its new "breakthrough" designation for a Who's Who in drug development, with high-profile companies like J&J, ...
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS